Biblio Discovery — Demo Discovery Service

29 hasil untuk "David Peterhoff"

Menampilkan 1–20 · 0,73 detik · RSS

  1. Artikel Jurnal

    Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab

    Clara Luzia Magnus; Andreas Hiergeist; Philipp Schuster dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Class 1 and 2 monoclonal antibodies inhibit SARS-CoV-2 entry by blocking the interaction of the viral receptor-binding domain with angiotensin-converting enzyme 2 (ACE2), while class 3 antibodies target a highly conserved epitope outside the ACE2 binding site. We aimed to investigate the plasticity…

  2. Artikel Jurnal

    Expanding the Genetic Code of Lactococcus lactis and Escherichia coli to Incorporate Non-canonical Amino Acids for Production of Modified Lantibiotics

    Maike Bartholomae; Tobias Baumann; Jessica H. Nickling dkk.

    Frontiers in Microbiology, Vol. 9 · 2018 · Inggris · DOAJ Scopus

    The incorporation of non-canonical amino acids (ncAAs) into ribosomally synthesized and post-translationally modified peptides, e.g., nisin from the Gram-positive bacterium Lactococcus lactis, bears great potential to expand the chemical space of various antimicrobials. The ncAA Nε-Boc-L-lysine…

  3. Artikel Jurnal

    Population-based study of the durability of humoral immunity after SARS-CoV-2 infection

    David Peterhoff; Simon Wiegrebe; Sebastian Einhauser dkk.

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    SARS-CoV-2 antibody quantity and quality are key markers of humoral immunity. However, there is substantial uncertainty about their durability. We investigated levels and temporal change of SARS-CoV-2 antibody quantity and quality. We analyzed sera (8 binding, 4 avidity assays for spike-(S-)protein…

  4. Artikel Jurnal

    Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination

    Markus Bauswein; David Peterhoff; Annelie Plentz dkk.

    iScience, Vol. 25 No. 2 · 2022 · Inggris · DOAJ Scopus

    Summary: Heterologous SARS-CoV-2 vaccine approaches with a second mRNA-based vaccine have been favored in the recommendations of many countries over homologous vector-based ChAdOx1 nCoV-19 vaccination after reports of thromboembolic events and lower efficacy of this regimen. In the middle of 2021…

  5. Artikel Jurnal Teks lengkap

    Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2

    Stilla Bauernfeind; Bernd Salzberger; Florian Hitzenbichler dkk.

    Vaccines, Vol. 9 No. 10 · 2021 · Inggris · DOAJ Scopus

    It is not clear whether there is an association between adverse reactions and immune response after vaccination. Seven hundred and thirty-five vaccinees from our University Medical Center vaccination clinic provided information about sex, age and adverse reactions after first and second vaccination…

  6. Artikel Jurnal Teks lengkap

    Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination

    Stilla Bauernfeind; Sebastian Einhauser; Leonid Tydykov dkk.

    Vaccines, Vol. 10 No. 10 · 2022 · Inggris · DOAJ Scopus

    In a previous study, we described a highly significant association between reactogenicity and SARS-CoV-2 RBD IgG titers and wild-type neutralization capacity in males after basic vaccination with BNT162b2. The objective of this study was to assess whether this benefit was long lasting and also…

  7. Artikel Jurnal

    Case report: Local bacteriophage therapy for fracture-related infection with polymicrobial multi-resistant bacteria: hydrogel application and postoperative phage analysis through metagenomic sequencing

    Volker Alt; André Gessner; Maya Merabishvili dkk.

    Frontiers in Medicine, Vol. 11 · 2024 · Inggris · DOAJ Scopus

    Fracture-related infections can be challenging, particularly with concomitant severe bone defects and multi-resistant microorganisms. We present a case of a 42-year-old patient with a fracture-related infection following a war injury from a gunshot, resulting in a 12-cm subtrochanteric segmental…

  8. Artikel Jurnal

    DNA extraction from clotted blood in genotyping quality

    Kira J Stanzick; Josef Simon; Martina E Zimmermann dkk.

    BioTechniques, Vol. 74 No. 1 · 2023 · Inggris · DOAJ Scopus

    DNA extraction from frozen blood clots is challenging. Here, the authors applied QIAGEN Clotspin Baskets and the Gentra Puregene Blood Kit for DNA extraction to cellular fraction of 5.5 ml whole blood without anticoagulating additives. The amount and quality of extracted DNA were assessed via…

  9. Artikel Jurnal

    Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis

    Jonas Maurice Holzinger; Martina Toelge; Maren Werner dkk.

    eLife, Vol. 12 · 2023 · Inggris · DOAJ

    Chronic pulmonary infection is a hallmark of cystic fibrosis (CF) and requires continuous antibiotic treatment. In this context, Pseudomonas aeruginosa (Pa) is of special concern since colonizing strains frequently acquire multiple drug resistance (MDR). Bactericidal/permeability-increasing protein…

  10. Artikel Jurnal Teks lengkap

    Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation

    Sebastian Einhauser; David Peterhoff; Hans Helmut Niller dkk.

    Diagnostics, Vol. 11 No. 10 · 2021 · Inggris · DOAJ Scopus

    Antibody testing for determining the SARS-CoV-2 serostatus was rapidly introduced in early 2020 and since then has been gaining special emphasis regarding correlates of protection. With limited access to representative samples with known SARS-CoV-2 infection status during the initial period of test…

  11. Artikel Jurnal Teks lengkap

    Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery

    David Peterhoff; Stefanie Thalhauser; Jan M. Sobczak dkk.

    Vaccines, Vol. 9 No. 6 · 2021 · Inggris · DOAJ Scopus

    The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm…

  12. Artikel Jurnal Teks lengkap

    Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality

    Viola Hähnel; David Peterhoff; Veronika Bäuerlein dkk.

    PLOS ONE, Vol. 15 No. 12 · 2020 · Inggris · PLOS Scopus

    The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19…

    Juga tersedia di: DOAJ

  13. Artikel Jurnal Teks lengkap

    Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants

    David Peterhoff; Sebastian Einhauser; Stephanie Beileke dkk.

    Vaccines, Vol. 10 No. 2 · 2022 · Inggris · DOAJ Scopus

    To assess vaccine immunogenicity in non-infected and previously infected individuals in a real-world scenario, SARS-CoV-2 antibody responses were determined during follow-up 2 (April 2021) of the population-based Tirschenreuth COVID-19 cohort study comprising 3378 inhabitants of the Tirschenreuth…

  14. Artikel Jurnal

    Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants

    George W. Carnell; Martina Billmeier; Sneha Vishwanath dkk.

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    The accelerated development of the first generation COVID-19 vaccines has saved millions of lives, and potentially more from the long-term sequelae of SARS-CoV-2 infection. The most successful vaccine candidates have used the full-length SARS-CoV-2 spike protein as an immunogen. As expected of RNA…

  15. Artikel Jurnal Teks lengkap

    Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses

    Alexandra Hauser; George Carnell; Kathrin Held dkk.

    Vaccines, Vol. 9 No. 7 · 2021 · Inggris · DOAJ Scopus

    Stabilization of the HIV-1 Envelope glycoprotein trimer (Env) in its native pre-fusion closed conformation is regarded as one of several requirements for the induction of neutralizing antibody (nAb) responses, which, in turn, will most likely be a prerequisite for the development of an efficacious…

  16. Artikel Jurnal

    Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits

    Frederik Radvan; Alexandra Hauser; Li-Yun Lin dkk.

    npj Vaccines, Vol. 11 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Developing an effective human immunodeficiency virus (HIV) vaccine remains challenging due to difficulties to induce antibodies that neutralize the wide range of HIV-variants. Native-like HIV envelope (Env) trimers in a closed conformation represent promising immunogens. We evaluated the…

  17. Artikel Jurnal

    Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals

    Anna-Lena Mader; Leonid Tydykov; Vivian Glück dkk.

    iScience, Vol. 25 No. 4 · 2022 · Inggris · DOAJ Scopus

    Summary: SARS-CoV-2 Omicron is the first pandemic variant of concern exhibiting an abrupt accumulation of mutations particularly in the receptor-binding domain that is a critical target of vaccination induced and therapeutic antibodies. Omicron's mutations did only marginally affect the binding of…

  18. Artikel Jurnal

    Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses

    Beatriz Perdiguero; Carmen Elena Gómez; Juan García-Arriaza dkk.

    Frontiers in Immunology, Vol. 10 · 2019 · Inggris · DOAJ Scopus

    The generation of a vaccine against HIV-1 able to induce durable protective immunity continues a major challenge. The modest efficacy (31.2%) of the phase III RV144 clinical trial provided the first demonstration that a prophylactic HIV/AIDS vaccine is achievable but emphasized the need for further…